PROFILE

Professor Susana Banerjee (MBBS MA PhD FRCP) is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit at The Royal Marsden, London, UK. She is Professor in Women's Cancers and Team Leader at the Institute of Cancer Research. Prof Banerjee specialises in ovarian cancer and the systemic treatment of endometrial and cervical cancers.

Prof Banerjee graduated with a 1st class in Physiology from St John’s College, University of Cambridge. She was president of the Cambridge Medical Society in 1996-1997. She completed her medical training in 2000 at The Royal Free/University College London Medical School where she was a University of London Gold Medal finalist. Prof Banerjee gained a PhD from The Institute of Cancer Research in 2009, University of London and was awarded the San Antonio Breast Cancer Symposium Novartis Oncology Basic Science Award for her research. Other prizes include the Association of Cancer Physicians McElwain Prize, the Sir Antony Driver Prize and the Pfizer British Oncology Association Young Investigator Award (highly commended).  In 2023 Prof Banerjee received the Fellow of ESMO (FESMO) Award.

Prof Banerjee has served in international specialist groups including; the European Society of Medical Oncology (ESMO) Executive Board as Director of Membership (2020-2022). She chairs the ESMO Resilience Task Force and was part of the ESMO Women for Oncology Committee. She was Track Chair for Gynaecological Cancers for the ESMO Congress 2018, Scientific Co-Chair for ESMO Asia 2018 and Co-Chair of the ESMO Gynaecological Cancers Congress 2021-2024. She is currently co-chair of the Gynecological Cancer InterGroup (GCIG) Rare Cancers Committee. She is a Theme Lead (Cancer Treatment Effects) for the National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research. Prof Banerjee has also served in the European Organization for Research and Treatment of Cancer (EORTC), the Executive Steering Committee for Gynaecological Cancers, ESGO (European Society of Gynaecological Oncology) Congress Faculty and International Gynecological Cancer Society Scientific Program Committee. She is President-Elect of the Royal Society of Medicine Oncology Section.

Prof Banerjee develops and participates in clinical trials; collaborates with leading scientists pushing forward the findings of early phase studies through effective drug development contributing to setting new standards of care. She is an author of over 175 peer-reviewed publications including in the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology and Annals of Oncology. Her research interests include individualisation of patient treatment, targeted therapies (including PARP inhibitors) and rare gynaecological cancers. Prof Banerjee has Global and UK Chief Investigator roles of over 30 national and international clinical trials. 

In addition to her NHS, research and leadership roles, Prof Banerjee has a private practice at The Royal Marsden, where she provides consultations and treatment for women with gynaecological cancers.  She is passionate about training a new generation of oncologists and healthcare professionals globally. Prof Banerjee also serves on the International Cancer Foundation Board supporting activities with the goal of ensuring the best treatment is available to every cancer patient.